neuro-oncology
Generated by DeepSeek V3.2Expansion Funnel Raw 92 → Dedup 0 → NER 0 → Enqueued 0
| neuro-oncology | |
|---|---|
| Name | Neuro-oncology |
| Diseases | Brain tumor, Spinal cord tumor, Leptomeningeal disease |
| Tests | Magnetic resonance imaging, Computed tomography, Biopsy, Lumbar puncture |
| Specialist | Neurologist, Neurosurgeon, Radiation oncologist, Medical oncologist |
| Organizations | Society for Neuro-Oncology, European Association of Neuro-Oncology, World Health Organization |
neuro-oncology is the medical subspecialty focused on the diagnosis, treatment, and research of cancers affecting the central nervous system. It is a highly interdisciplinary field that integrates expertise from neurology, neurosurgery, radiation oncology, and medical oncology to manage complex conditions like glioblastoma and medulloblastoma. The field addresses both primary tumors arising from brain or spinal cord tissue and secondary metastatic tumors that spread from cancers elsewhere in the body, such as lung cancer or breast cancer. Practitioners work to improve survival and quality of life for patients facing these challenging diseases.
Overview
The discipline coalesced in the late 20th century, driven by advances in neuroimaging and the formation of dedicated professional societies like the Society for Neuro-Oncology in the United States. Core practice involves managing a spectrum of neoplasms, from the often benign meningioma to highly aggressive glioblastoma multiforme. Specialists frequently collaborate within multidisciplinary teams at major cancer centers, including the MD Anderson Cancer Center and the Memorial Sloan Kettering Cancer Center. The field also encompasses the study and treatment of complications like peritumoral edema and seizures caused by these tumors.
Types of brain and spinal cord tumors
Tumors are classified based on the cell of origin, as defined by the World Health Organization classification of tumours of the central nervous system. Common primary glial tumors include astrocytoma, oligodendroglioma, and ependymoma. Notable neuronal and mixed neuronal-glial tumors are ganglioglioma and dysembryoplastic neuroepithelial tumor. Among embryonal tumors, medulloblastoma is a frequent pediatric malignancy. Other critical types are pineal gland tumors, such as pineoblastoma, and tumors of the sellar region like pituitary adenoma. Primary central nervous system lymphoma represents a distinct category, often associated with conditions like HIV/AIDS.
Diagnosis and staging
Initial assessment typically involves advanced neuroimaging techniques, primarily contrast-enhanced magnetic resonance imaging and, in some cases, computed tomography. Positron emission tomography using tracers like fluoroethyltyrosine can help differentiate tumor recurrence from radiation necrosis. Definitive diagnosis usually requires a stereotactic biopsy or craniotomy for tissue analysis. Lumbar puncture for cerebrospinal fluid cytology is crucial for diagnosing leptomeningeal disease. Molecular profiling, including tests for IDH mutation, 1p/19q co-deletion, and MGMT promoter methylation, has become integral to modern diagnostic and prognostic stratification.
Treatment modalities
The cornerstone of treatment for accessible tumors is maximal safe resection performed by a neurosurgeon, often aided by technologies like intraoperative MRI and awake craniotomy. Radiation therapy, including advanced techniques like stereotactic radiosurgery pioneered at institutions like Karolinska Institutet, is a mainstay for many tumors. Systemic therapies include temozolomide for glioblastoma and procarbazine, lomustine, and vincristine for oligodendroglioma. Targeted therapy agents, such as bevacizumab for reducing edema, and immunotherapy approaches, including checkpoint inhibitors, are areas of active clinical investigation through groups like the Radiation Therapy Oncology Group.
Prognosis and outcomes
Prognosis varies dramatically by tumor type, molecular profile, and patient factors. Glioblastoma carries a poor median survival despite aggressive treatment with temozolomide and radiation, while pilocytic astrocytoma often has an excellent prognosis following surgery. The Recursive Partitioning Analysis classification historically helped stratify outcomes. Long-term survivors often face significant challenges, including cognitive deficits, endocrine dysfunction, and risk of secondary malignancies. Quality-of-life metrics and management of neuropathic pain and fatigue are critical components of survivorship care, supported by organizations like the National Comprehensive Cancer Network.
Research and future directions
Current research is heavily focused on understanding tumor genomics through initiatives like The Cancer Genome Atlas. Novel therapeutic strategies under investigation include oncolytic virus therapy, chimeric antigen receptor T-cell therapy, and convection-enhanced delivery of agents. Clinical trials are exploring the efficacy of next-generation alkylating agents and combinations of immunotherapy with radiation. International consortia, such as the European Organisation for Research and Treatment of Cancer and the Children's Oncology Group, are pivotal in conducting large-scale studies to improve standards of care and develop personalized medicine approaches for both adult and pediatric patients.